Loading...
Captopril — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Captopril
2025-Q4
Comprehensive analysis of India’s captopril export trade — suppliers, buyers, prices, routes, and every shipment record.
87
Shipments
$616K
Trade Value
41
Suppliers
33
Buyers
34
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/captopril
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s captopril trade — 2025-Q4
KEY TAKEAWAY
Captopril 2025-Q4 exports total $616.2K across 34 countries, with AGOG PHARMA LTD commanding 16.6% market share.
TOTAL SHIPMENTS
87
2025-Q4
EXPORT VALUE
$616.2K
FOB USD
TOTAL QUANTITY
9.5M
units shipped
INDIAN SUPPLIERS
41
unique exporters
GLOBAL BUYERS
33
unique importers
DESTINATIONS
34
countries
MEDIAN UNIT PRICE
$0.637
per unit
TOP-5 SHARE
57.1%
of total USD
BRANDED SHARE
63.2%
55 shipments
DOSAGE FORMS
2
product types
6 KEY FINDINGS
1
AGOG PHARMA LTD is India's #1 Captopril exporter with $102.3K (16.6% market share).→ §5, Indian Supplier Rankings
2
Captopril reached 34 countries, with Kenya as the top destination ($100.9K).→ §4, Global Destination Map
3
Market concentration is low (HHI: 842) — top 10 suppliers control 79.3% of exports.→ §5, Indian Supplier Rankings
4
93.9% of buyers (31 of 33) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (77.5%) across 2 dosage forms.→ §7, Price Benchmarks
6
34 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 AGOG PHARMA LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian captopril exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Captopril report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial captopril trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian captopril suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Captopril India trade report
Product scope
Captopril
All variants merged — branded and generic formulations of captopril
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
87
Every commercial captopril trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a v-curve: Oct $392.1K, Nov $56.9K, Dec $167.3K. Shipment counts were mixed across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$392.1K
Oct USD
33 shipments
2
$56.9K
Nov USD
-85.5% MoM
3
$167.3K
Dec USD
+194.0% MoM
4
V-curve
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 85.5% in USD but shipment count kept steady.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $392K, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $616K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $335K dip in Nov, $110K recovery in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $392K | 33 shipments |
| Nov | $57K | 28 shipments |
| Dec | $167K | 26 shipments |
| Q4 Total | $616K | 87 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Dominican Republic held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: BALAXI PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import captopril from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Kenya absorbs 16.4% of India’s 2025-Q4 captopril trade ($100.9K). Beyond the top 10 destinations, 34 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 18 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 34 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much captopril India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$31K
5.0% of trade
5 countries · 10 shipments
Europe
$192K
31.1% of trade
4 countries · 6 shipments
Americas
$76K
12.3% of trade
6 countries · 19 shipments
Africa
$318K
51.5% of trade
18 countries · 51 shipments
Oceania
$210
0.0% of trade
1 countries · 1 shipments
Fig 4.1 Kenya is the #1 corridor ($101K) — 30 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian captopril it receives (light = low, dark = high). Orange arcs radiate from India to the top 30 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Kenya | $101K | 1 | AGOG PHARMA LTD | $101K | — | — | — | — |
| 2 | United Kingdom | $75K | 1 | GENO PHARMACEUTICALS PVT LTD | $75K | — | — | — | — |
| 3 | Romania | $69K | 1 | ZENTIVA PVT LTD | $69K | — | — | — | — |
| 4 | Sierra Leone | $60K | 2 | MIHIKA PHARMACEUTICALS | $60K | — | — | — | — |
| 5 | South Africa | $57K | 12 | MEDISKY PHARMACEUTICALS PVT LTD | $38K | J B CHEMICALS AND PHARMACEUTICALS LTD | $15K | SARTHI PHARMA | $5K |
| 6 | Dominican Republic | $51K | 8 | AMICO FORMULATIONS LLP | $24K | BALAXI PHARMACEUTICALS LTD | $14K | ANH PHARMACEUTICALS PVT LTD | $8K |
| 7 | Belgium | $42K | 3 | GRACURE PHARMACEUTICALS LTD | $42K | — | — | — | — |
| 8 | Uganda | $26K | 3 | TORRENT PHARMACEUTICALS LTD | $26K | — | — | — | — |
| 9 | Angola | $22K | 6 | UMAVIDA PHARMA PVT LTD | $13K | ANETA PHARMACEUTICALS PVT LTD | $5K | VIAN INTERNATIONAL | $4K |
| 10 | Nepal | $18K | 6 | SANOFI INDIA LTD | $18K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 5.0% of USD — but Kenya is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
16.4%
#1 country share
Kenya alone
58.8%
Top 5 share
5 of 34 countries
93.8%
Top 15 share
Long tail of 19 countries = 6.2%
HHI 900
Destination HHI
Competitive spread
34
Countries served
Global pharma reach from India
18
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
41 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
AGOG PHARMA LTD ($102.3K, 16.6% share) and GENO PHARMACEUTICALS PVT LTD ($75.3K) together control 28.8% of India’s 2025-Q4 captopril trade. The top 5 suppliers hold 57.1%. 41 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian captopril suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 AGOG PHARMA LTD leads by $27K over GENO PHARMACEUTICALS PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: GENO PHARMACEUTICALS PVT is #2 by value but #14 by volume.
Fig 5.2 TORRENT PHARMACEUTICALS LTD also leads by shipment count (7) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: GENO PHARMACEUTICALS PVT moves from #14 by volume to #2 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 41 captopril suppliers split into strategic segments
KEY TAKEAWAY
11 suppliers (25%) generate 81.6% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 AGOG PHARMA LTD and GENO PHARMACEUTICALS PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 81.6% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | AGOG PHARMA LTD | 1 | 2 | $102K |
| 2 | GENO PHARMACEUTICALS PVT LTD | 1 | 1 | $75K |
| 3 | ZENTIVA PVT LTD | 1 | 1 | $69K |
| 4 | MIHIKA PHARMACEUTICALS | 1 | 1 | $60K |
| 5 | TORRENT PHARMACEUTICALS LTD | 1 | 3 | $45K |
| 6 | GRACURE PHARMACEUTICALS LTD | 1 | 1 | $42K |
| 7 | MEDISKY PHARMACEUTICALS PVT LTD | 1 | 1 | $38K |
| 8 | AMICO FORMULATIONS LLP | 1 | 1 | $24K |
| 9 | SANOFI INDIA LTD | 1 | 1 | $18K |
| 10 | J B CHEMICALS AND PHARMACEUTICALS LTD | 1 | 1 | $15K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the captopril manufacturing hubs
KEY TAKEAWAY
Mumbai and Vasai East together account for $264K of India’s 2025-Q4 captopril trade.
Fig 5.5 Mumbai (8 exporters, $161K) and Vasai East (1 exporters, $102K) are India’s captopril capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
57.1%
Top 5 share
5 of 41 suppliers
79.3%
Top 10 share
10 of 41 suppliers
81.6%
Top 25% share
11 suppliers = 82% USD
HHI 842
Supplier HHI
Competitive
41
Total suppliers
shipped Captopril in 2025-Q4
20+ cities
Indian hubs
Mumbai and Vasai East lead
§5.2 Coming next: 1 exporter deep-dive profiles
Each of the top 1 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | TORRENT PHARMACEUTICALS LTD | $45K |
#5
EXPORTER PROFILE #1 OF 1
TORRENT PHARMACEUTICALS LTD
Ahmedabad. Gujarat · India’s #5 captopril supplier by USD · 2025-Q4
2025-Q4 USD
$45K
7.4% market share
SHIPMENTS
7
avg $6K/ship
COUNTRIES
3
destination markets
BUYERS
3
3 single-sourced
BRANDED
86%
of shipments
DOSAGE FORMS
1
product types
TOP 3 DESTINATIONS
Uganda is the #1 market at $26K (56% of trade), followed by Sri Lanka at $12K. 3 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Uganda | $26K | 3 | 56.4% |
| 2 | Sri Lanka | $12K | 1 | 27.3% |
| 3 | Zimbabwe | $7K | 3 | 16.3% |
MONTHLY TREND
Nov peaked at $28K. Oct was the weakest at $3K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| KARURI PHARMACEUTICALS… | Uganda | $26K | ⚠ Locked |
| HATTON NATIONAL BANK PLC | Sri Lanka | $12K | ⚠ Locked |
| PHARMACEUTICAL AND CHE… | Zimbabwe | $7K | ⚠ Locked |
#5
EXPORTER PROFILE #1 OF 1 — TRADE FLOW MAP
TORRENT PHARMACEUTICALS LTD — Supplier → Country → Importer
3 destination countries, top 5 importers per country
Fig 5.P1.3 Uganda absorbs $26K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 3 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
33 importers across 34 countries — who is buying Indian captopril and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 67.6% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian captopril. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 RWANDA MEDICAL SUPPLY LTD is the #1 importer at $101K (16.4%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
94%
Single-source
31 buyers rely on exactly 1 Indian supplier
3%
Dual-source
1 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
3%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source captopril from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Dominican Republic 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BALAXI HEALTHCARE DOMI… | BALAXI PHARMACEUTICA… | $14K | $0.636 | Tablet |
| TO THE ODRER OF AARNEX… | ANH PHARMACEUTICALS … | $8K | $5.027 | Tablet |
| BERYL PHARMA SRL | CUMED LIFESCIENCES | $5K | $0.772 | Tablet |
Tanzania 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ARAUPHAR S.A | AURA LIFECARE PVT LTD | $5K | $0.465 | Tablet |
| SHALINA HEALTHCARE SARL | SHALINA LABORATORIES… | $3K | $0.769 | Tablet |
| SUN ENTERPRISES LTD | AGOG PHARMA LTD | $1K | $287.672 | Tablet |
Equatorial Guinea 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SONIA PHARMACIA | REGAL LABORATORIES | $8K | $16.696 | Tablet |
| SONIA PHARMACY | REGAL LABORATORIES | $3K | $22.810 | Tablet |
Kenya 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| RWANDA MEDICAL SUPPLY … | AGOG PHARMA LTD | $101K | $330.855 | Tablet |
United Kingdom 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| CRESCENT PHARMA LTD | GENO PHARMACEUTICALS… | $75K | $0.402 | Capsule |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | RWANDA MEDICAL SUPPL… | Kenya | $101K | $101K | Premium |
| 2 | CRESCENT PHARMA LTD | United Kingdom | $75K | $75K | Premium |
| 3 | ZENTIVA S.A | Romania | $69K | $69K | Premium |
| 4 | KARURI PHARMACEUTICA… | Uganda | $26K | $9K | Budget |
| 5 | YETI PHARMACHEM DIST… | Nepal | $18K | $3K | Budget |
| 6 | BIOTECH LABORATORIES… | South Africa | $15K | $3K | Budget |
| 7 | MCKESSON THIRD PARTY… | United States | $14K | $3K | Budget |
| 8 | BALAXI HEALTHCARE DO… | Dominican Republic | $14K | $4K | Budget |
| 9 | HATTON NATIONAL BANK… | Sri Lanka | $12K | $12K | Budget |
| 10 | KERSTEN DISTRIBUTION… | Suriname | $11K | $11K | Budget |
| 11 | TO THE ODRER OF AARN… | Dominican Republic | $8K | $8K | Budget |
| 12 | SONIA PHARMACIA | Equatorial Guinea | $8K | $4K | Budget |
| 13 | PHARMACEUTICAL AND C… | Zimbabwe | $7K | $2K | Budget |
| 14 | IMRES B.V | Netherlands | $6K | $6K | Budget |
| 15 | UNIPLUS FARMA,LDA | Angola | $5K | $3K | Budget |
| 16 | BERYL PHARMA SRL | Dominican Republic | $5K | $2K | Budget |
| 17 | ARAUPHAR S.A | Tanzania | $5K | $5K | Budget |
| 18 | UNIQUE PHARMA | DR Congo | $4K | $4K | Budget |
| 19 | PHARMA ESPOIR SARL | Cote d'Ivoire | $4K | $2K | Budget |
| 20 | SHALINA HEALTHCARE S… | Tanzania | $3K | $3K | Budget |
| 21 | SONIA PHARMACY | Equatorial Guinea | $3K | $1K | Budget |
| 22 | T.CHOITHRAM & SONS (… | Liberia | $2K | $964.000 | Budget |
| 23 | SUN ENTERPRISES LTD | Tanzania | $1K | $1K | Budget |
| 24 | GOOD HEALTH (PTY) LTD | Seychelles | $579.060 | $290.000 | Budget |
| 25 | ALLIANCE PHARMA SARL | Guinea-Bissau | $389.877 | $390.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 AGOG PHARMA LTD → RWANDA MEDICAL SUPPLY LTD is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian captopril prices vary by supplier, country and dosage form
KEY TAKEAWAY
Captopril prices span 3613509× ($0.0001 → $428.71). The coefficient of variation is 3.88. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0001 | Lowest observed unit price |
| P5 | $0.0068 | 5th percentile |
| P25 | $0.121 | 25th percentile (Q1) |
| Median | $0.637 | 50th percentile (Q2) |
| P75 | $2.18 | 75th percentile (Q3) |
| P95 | $38.57 | 95th percentile |
| Max | $428.71 | Highest observed unit price |
| Mean | $17.62 | Arithmetic average |
| CV | 388% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 MIHIKA PHARMACEUTICALS prices at $310.81/unit vs market median $0.637.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. TORRENT PHARMACEUTICALS LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. AGOG PHARMA LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. GENO PHARMACEUTICALS PVT Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. AMICO FORMULATIONS LLP Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | MIHIKA PHARMACEU… | Sierra Leone | Capsule | 140 | $60K | $428.71 | Specialty / small-batch |
| Oct 2025 | AGOG PHARMA LTD | Kenya | Tablet | 305 | $101K | $330.86 | Specialty / small-batch |
| Nov 2025 | AGOG PHARMA LTD | Tanzania | Tablet | 5 | $1K | $287.67 | Specialty / small-batch |
| Dec 2025 | MIHIKA PHARMACEU… | Sierra Leone | Capsule | 1 | $192.92 | $192.92 | Specialty / small-batch |
| Nov 2025 | REGAL LABORATORIES | Equatorial Guinea | Tablet | 31 | $1K | $39.56 | Specialty / small-batch |
| Dec 2025 | SANITAS MEDTECH … | Singapore | Tablet | 6 | $197.40 | $32.90 | Specialty / small-batch |
| Dec 2025 | REGAL LABORATORIES | Equatorial Guinea | Tablet | 91 | $2K | $24.72 | Specialty / small-batch |
| Nov 2025 | REGAL LABORATORIES | Equatorial Guinea | Tablet | 44 | $953.21 | $21.81 | Specialty / small-batch |
| Dec 2025 | REGAL LABORATORIES | Equatorial Guinea | Tablet | 372 | $5K | $14.75 | Specialty / small-batch |
| Nov 2025 | REGAL LABORATORIES | Equatorial Guinea | Tablet | 57 | $826.12 | $14.42 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | TULSI MEDICAL & … | Panama | Capsule | 9 | $0.031 | $0.0034 | Small sample / trial shipment |
| Nov 2025 | AJANTA PHARMA LTD | United States | Tablet | 29K | $119.08 | $0.0041 | Bulk generic tablet |
| Nov 2025 | AJANTA PHARMA LTD | United States | Tablet | 29K | $119.08 | $0.0041 | Bulk generic tablet |
| Nov 2025 | AJANTA PHARMA LTD | United States | Tablet | 721K | $5K | $0.0067 | Bulk generic tablet |
| Dec 2025 | AJANTA PHARMA LTD | United States | Tablet | 563K | $4K | $0.0076 | Bulk generic tablet |
| Dec 2025 | AJANTA PHARMA LTD | United States | Tablet | 563K | $4K | $0.0076 | Bulk generic tablet |
| Nov 2025 | TORRENT PHARMACE… | Sri Lanka | Tablet | 1.4M | $12K | $0.0086 | Bulk generic tablet |
| Oct 2025 | J B CHEMICALS AN… | South Africa | Tablet | 954K | $10K | $0.010 | |
| Oct 2025 | J B CHEMICALS AN… | South Africa | Tablet | 480K | $5K | $0.010 | |
| Nov 2025 | TORRENT PHARMACE… | Zimbabwe | Tablet | 208K | $2K | $0.012 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship captopril, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Captopril leaves India through 17+ ports. The top 5 (NHAVA SHEVA SEA (JNPT), AHMEDABAD ICD, PATLI ICD) handle 91.4% of total USD. SEA moves 45% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 NHAVA SHEVA SEA (JNPT) handles $406K — top 17 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Kigali is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 45% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$425K
69.0% of USD · 44.8% of ships
ICD
$129K
20.9% of USD · 25.3% of ships
AIR
$44K
7.2% of USD · 23.0% of ships
ROAD
$18K
2.9% of USD · 6.9% of ships
Fig 8.3 The dominant corridor is NHAVA SHEVA SEA (JNPT) → Sea → Africa ($197K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
United States is the most concentrated destination (HHI 10000, 1 suppliers). Dominican Republic is the most competitive (HHI 3323).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 United States (HHI 10,000) is the most concentrated — Dominican Republic (HHI 3,323) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| RWANDA MEDICAL SUPPL… | Kenya | AGOG PHARMA LTD | $101K | 1 | HIGH |
| CRESCENT PHARMA LTD | United Kingdom | GENO PHARMACEUTI… | $75K | 1 | MEDIUM |
| ZENTIVA S.A | Romania | ZENTIVA PVT LTD | $69K | 1 | MEDIUM |
| KARURI PHARMACEUTICA… | Uganda | TORRENT PHARMACE… | $26K | 3 | MEDIUM |
| YETI PHARMACHEM DIST… | Nepal | SANOFI INDIA LTD | $18K | 6 | MEDIUM |
| BIOTECH LABORATORIES… | South Africa | J B CHEMICALS AN… | $15K | 5 | MEDIUM |
| MCKESSON THIRD PARTY… | United States | AJANTA PHARMA LTD | $14K | 5 | MEDIUM |
| BALAXI HEALTHCARE DO… | Dominican Republic | BALAXI PHARMACEU… | $14K | 4 | MEDIUM |
Conclusion: 31 buyers depend on exactly one Indian supplier, representing $417K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Kenya | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| United Kingdom | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Romania | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Sierra Leone | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Dominican Republic | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Belgium | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Uganda | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Angola | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| United States | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Equatorial Guinea | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Suriname | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Tanzania | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 12 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Kenya | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit United States lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Dominican Republic (4 suppliers) | This Q | HIGH |
| A6 | Enter United States (1 suppliers) | This Q | MED |
| A8 | Build United Kingdom distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (TORRENT PHARMACEUTICALS) | This Q | MED |
| A7 | Register for Kenya tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Dominican Republic | Other | 4 | $51K | +665.5% | LOW | Growing 666% with only 4 competitors |
| 2 | United States | Other | 1 | $14K | +993.7% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Kenya | Africa | 1 | $101K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Angola | Africa | 3 | $22K | +349.5% | LOW | Growing 350% with only 3 competitors |
| 5 | United Kingdom | Other | 1 | $75K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Romania | Other | 1 | $69K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Sierra Leone | Africa | 1 | $60K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | South Africa | Africa | 3 | $57K | -90.8% | LOW | Low competition (3 suppliers), accessible market |
| 9 | Belgium | Other | 1 | $42K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Uganda | Africa | 1 | $26K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Nepal | Asia | 1 | $18K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Sri Lanka | Asia | 1 | $12K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Equatorial Guinea | Africa | 1 | $11K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Suriname | Other | 1 | $11K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Tanzania | Africa | 3 | $9K | 0% | LOW | Low competition (3 suppliers), accessible market |
This report covers 87 2025-Q4 Captopril shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/captopril
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 87 2025-Q4 captopril shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian captopril shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
87
across all regions
TOTAL USD
$616K
2025-Q4 FOB value
UNITS
9.5M
tablets, capsules, etc.
SUPPLIERS
41
Indian exporters
BUYERS
33
global importers
COUNTRIES
34
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $318K (51.5%), spanning 18 countries.
41 Indian suppliers shipped to 33 buyers across 34 countries — average shipment value $7K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
18 countries · 51 shipments · $318K · 23 Indian suppliers · 18 buyers
SHIPMENTS
51
USD
$318K
COUNTRIES
18
SUPPLIERS
23
BUYERS
18
HHI
1,718
moderate
Top 18 destination countries in Africa
1
Kenya (31.8%)
$101K
2
Sierra Leone (19.0%)
$60K
3
South Africa (18.1%)
$57K
4
Uganda (8.1%)
$26K
5
Angola (6.9%)
$22K
6
Equatorial Guinea (3.4%)
$11K
7
Tanzania (2.9%)
$9K
8
Malawi (2.7%)
$8K
9
Zimbabwe (2.3%)
$7K
10
DR Congo (1.3%)
$4K
11
Cote d'Ivoire (1.2%)
$4K
12
Mozambique (0.7%)
$2K
13
Cameroon (0.7%)
$2K
14
Liberia (0.6%)
$2K
15
Seychelles (0.3%)
$983.58
16
Guinea-Bissau (0.1%)
$389.88
17
Chad (0.1%)
$282.58
18
Zambia (0.0%)
$23.75
Top 23 Indian suppliers into Africa
1
AGOG PHARMA LTD
$102K
2
MIHIKA PHARMACEUTICALS
$60K
3
MEDISKY PHARMACEUTICALS PVT LTD
$38K
4
TORRENT PHARMACEUTICALS LTD
$33K
5
J B CHEMICALS AND PHARMACEUTICALS LTD
$15K
6
UMAVIDA PHARMA PVT LTD
$13K
7
REGAL LABORATORIES
$11K
8
ANGEL BIOGENICS PVT LTD
$8K
9
ANETA PHARMACEUTICALS PVT LTD
$5K
10
SARTHI PHARMA
$5K
11
AURA LIFECARE PVT LTD
$5K
12
BIOMATRIX HEALTHCARE PVT LTD
$4K
13
VIAN INTERNATIONAL
$4K
14
BENLEX TRADING PVT LTD
$4K
15
SHALINA LABORATORIES PVT LTD
$3K
16
GLOBAL PHARMA HEALTHCARE PVT LTD
$2K
17
LAVITA PHARMA PVT LTD
$2K
18
GIANT INTERNATIONAL PVT LTD
$2K
19
JYOTI IMPEX
$579.06
20
CAPSTONE EXPORT & IMPORT
$404.52
21
TRIDENT IMPEX
$389.88
22
AKASH PHARMA EXPORTS
$282.58
23
MEDICOS LIFESCIENCES
$23.75
Top 17 Africa importers
1
RWANDA MEDICAL SUPPLY LTD · Kenya
$101K
2
KARURI PHARMACEUTICALS LTD · Uganda
$26K
3
BIOTECH LABORATORIES (PTY) LTDDELIV · South Africa
$15K
4
SONIA PHARMACIA · Equatorial Guinea
$8K
5
PHARMACEUTICAL AND CHEMICAL DISTRIB · Zimbabwe
$7K
6
UNIPLUS FARMA,LDA · Angola
$5K
7
ARAUPHAR S.A · Tanzania
$5K
8
UNIQUE PHARMA · DR Congo
$4K
9
PHARMA ESPOIR SARL · Cote d'Ivoire
$4K
10
SHALINA HEALTHCARE SARL · Tanzania
$3K
11
SONIA PHARMACY · Equatorial Guinea
$3K
12
T.CHOITHRAM & SONS ( LIB.) INC · Liberia
$2K
13
SUN ENTERPRISES LTD · Tanzania
$1K
14
GOOD HEALTH (PTY) LTD · Seychelles
$579.06
15
ALLIANCE PHARMA SARL · Guinea-Bissau
$389.88
16
AMDJERAS FIELD HOSPITAL · Chad
$282.58
17
LUSAKA PHARMA CHEM SUPPLIES LTD · Zambia
$23.75
Top 3 dosage forms
1
Tablet
$255K
2
Capsule
$62K
3
Unknown
$579.06
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 19 | $172K | $9K |
| Nov | 17 | $34K | $2K |
| Dec | 15 | $112K | $7K |
Shipment register · 51 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — AGOG PHARMA LTD · 2 shipments · $102K | |||||||||||
| 1 | Oct 2025 | RWANDA MEDICAL SUPPLY LTD | Kenya | Tablet | 305 | KGS | $330.86 | $101K | NHAVA SHEVA SEA (JNPT) | Kigali | SEA |
| 2 | Nov 2025 | SUN ENTERPRISES LTD | Tanzania | Tablet | 5 | KGS | $287.67 | $1K | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| SUPPLIER #2 — MIHIKA PHARMACEUTICALS · 2 shipments · $60K | |||||||||||
| 3 | Dec 2025 | UNLISTED BUYER | Sierra Leone | Capsule | 140 | NOS | $428.71 | $60K | NHAVA SHEVA SEA (JNPT) | Freetown | SEA |
| 4 | Dec 2025 | UNLISTED BUYER | Sierra Leone | Capsule | 1 | NOS | $192.92 | $192.92 | NHAVA SHEVA SEA (JNPT) | Freetown | SEA |
| SUPPLIER #3 — MEDISKY PHARMACEUTICALS PVT LTD · 5 shipments · $38K | |||||||||||
| 5 | Oct 2025 | UNLISTED BUYER | South Africa | Tablet | 16.8K | NOS | $0.471 | $8K | AHMEDABAD ICD | DURBAN | ICD |
| 6 | Oct 2025 | UNLISTED BUYER | South Africa | Tablet | 16.8K | NOS | $0.471 | $8K | AHMEDABAD ICD | DURBAN | ICD |
| 7 | Oct 2025 | UNLISTED BUYER | South Africa | Tablet | 16.8K | NOS | $0.471 | $8K | AHMEDABAD ICD | DURBAN | ICD |
| 8 | Oct 2025 | UNLISTED BUYER | South Africa | Tablet | 16.8K | NOS | $0.471 | $8K | AHMEDABAD ICD | DURBAN | ICD |
| 9 | Oct 2025 | UNLISTED BUYER | South Africa | Tablet | 12.9K | NOS | $0.471 | $6K | AHMEDABAD ICD | DURBAN | ICD |
| SUPPLIER #4 — TORRENT PHARMACEUTICALS LTD · 6 shipments · $33K | |||||||||||
| 10 | Oct 2025 | PHARMACEUTICAL AND CHEMICAL DISTRIB | Zimbabwe | Tablet | 224.0K | NOS | $0.013 | $3K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 11 | Nov 2025 | KARURI PHARMACEUTICALS LTD | Uganda | Tablet | 953.4K | NOS | $0.013 | $12K | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| 12 | Nov 2025 | KARURI PHARMACEUTICALS LTD | Uganda | Tablet | 70.0K | NOS | $0.013 | $877.33 | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| 13 | Nov 2025 | PHARMACEUTICAL AND CHEMICAL DISTRIB | Zimbabwe | Tablet | 208.0K | NOS | $0.012 | $2K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 14 | Dec 2025 | PHARMACEUTICAL AND CHEMICAL DISTRIB | Zimbabwe | Tablet | 149.8K | NOS | $0.013 | $2K | NHAVA SHEVA SEA (JNPT) | Harare | SEA |
| 15 | Dec 2025 | KARURI PHARMACEUTICALS LTD | Uganda | Tablet | 1.0M | NOS | $0.013 | $13K | MUMBAI AIR (SAHAR) | ENTEBBE | AIR |
| SUPPLIER #5 — J B CHEMICALS AND PHARMACEUTICALS LTD · 5 shipments · $15K | |||||||||||
| 16 | Oct 2025 | BIOTECH LABORATORIES (PTY) LTDDELIV | South Africa | Tablet | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 17 | Oct 2025 | BIOTECH LABORATORIES (PTY) LTDDELIV | South Africa | Tablet | 480.0K | NOS | $0.010 | $5K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 18 | Oct 2025 | BIOTECH LABORATORIES (PTY) LTDDELIV | South Africa | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA | |
| 19 | Oct 2025 | BIOTECH LABORATORIES (PTY) LTDDELIV | South Africa | Tablet | 1 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 20 | Oct 2025 | BIOTECH LABORATORIES (PTY) LTDDELIV | South Africa | Tablet | 954.0K | NOS | $0.010 | $10K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #6 — UMAVIDA PHARMA PVT LTD · 2 shipments · $13K | |||||||||||
| 21 | Dec 2025 | UNLISTED BUYER | Angola | Tablet | 10.0K | NOS | $0.553 | $6K | AHMEDABAD ICD | LUANDA | ICD |
| 22 | Dec 2025 | UNLISTED BUYER | Angola | Tablet | 10.0K | NOS | $0.733 | $7K | AHMEDABAD ICD | LUANDA | ICD |
| SUPPLIER #7 — REGAL LABORATORIES · 5 shipments · $11K | |||||||||||
| 23 | Nov 2025 | SONIA PHARMACY | Equatorial Guinea | Tablet | 44 | KGS | $21.81 | $953.21 | CHAWAPAYAL ICD | MALABO | ICD |
| 24 | Nov 2025 | SONIA PHARMACY | Equatorial Guinea | Tablet | 57 | KGS | $14.42 | $826.12 | CHAWAPAYAL ICD | MALABO | ICD |
| 25 | Nov 2025 | SONIA PHARMACY | Equatorial Guinea | Tablet | 31 | KGS | $39.56 | $1K | CHAWAPAYAL ICD | MALABO | ICD |
| 26 | Dec 2025 | SONIA PHARMACIA | Equatorial Guinea | Tablet | 91 | KGS | $24.72 | $2K | LUDHIANA ICD | BATA | ICD |
| 27 | Dec 2025 | SONIA PHARMACIA | Equatorial Guinea | Tablet | 372 | KGS | $14.75 | $5K | LUDHIANA ICD | BATA | ICD |
| SUPPLIER #8 — ANGEL BIOGENICS PVT LTD · 1 shipments · $8K | |||||||||||
| 28 | Oct 2025 | UNLISTED BUYER | Malawi | Tablet | 7.8K | NOS | $1.09 | $8K | AHMEDABAD ICD | Lilongwe | ICD |
| SUPPLIER #9 — ANETA PHARMACEUTICALS PVT LTD · 2 shipments · $5K | |||||||||||
| 29 | Dec 2025 | UNIPLUS FARMA,LDA | Angola | Tablet | 5.0K | NOS | $0.430 | $2K | AHMEDABAD ICD | LUANDA | ICD |
| 30 | Dec 2025 | UNIPLUS FARMA,LDA | Angola | Tablet | 4.9K | NOS | $0.601 | $3K | AHMEDABAD ICD | LUANDA | ICD |
| SUPPLIER #10 — SARTHI PHARMA · 2 shipments · $5K | |||||||||||
| 31 | Dec 2025 | UNLISTED BUYER | South Africa | Tablet | 12.2K | NOS | $0.358 | $4K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 32 | Dec 2025 | UNLISTED BUYER | South Africa | Tablet | 1.0K | NOS | $0.460 | $460.00 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #11 — AURA LIFECARE PVT LTD · 1 shipments · $5K | |||||||||||
| 33 | Dec 2025 | ARAUPHAR S.A | Tanzania | Tablet | 9.7K | NOS | $0.465 | $5K | MUNDRA SEA | Dar Es Salaam | SEA |
| SUPPLIER #12 — BIOMATRIX HEALTHCARE PVT LTD · 1 shipments · $4K | |||||||||||
| 34 | Nov 2025 | UNIQUE PHARMA | DR Congo | Tablet | 5.6K | NOS | $0.719 | $4K | AHMEDABAD ICD | MATADI | ICD |
| SUPPLIER #13 — VIAN INTERNATIONAL · 2 shipments · $4K | |||||||||||
| 35 | Oct 2025 | UNLISTED BUYER | Angola | Tablet | 530 | PCS | $3.20 | $2K | AHMEDABAD AIR | LUANDA - | AIR |
| 36 | Oct 2025 | UNLISTED BUYER | Angola | Tablet | 495 | PCS | $4.64 | $2K | AHMEDABAD AIR | LUANDA - | AIR |
| SUPPLIER #14 — BENLEX TRADING PVT LTD · 2 shipments · $4K | |||||||||||
| 37 | Nov 2025 | PHARMA ESPOIR SARL | Cote d'Ivoire | Tablet | 3.0K | NOS | $0.537 | $2K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| 38 | Nov 2025 | PHARMA ESPOIR SARL | Cote d'Ivoire | Tablet | 3.0K | NOS | $0.767 | $2K | NHAVA SHEVA SEA (JNPT) | Abidjan | SEA |
| SUPPLIER #15 — SHALINA LABORATORIES PVT LTD · 1 shipments · $3K | |||||||||||
| 39 | Nov 2025 | SHALINA HEALTHCARE SARL | Tanzania | Tablet | 4.0K | NOS | $0.769 | $3K | NHAVA SHEVA SEA (JNPT) | Dar Es Salaam | SEA |
| SUPPLIER #16 — GLOBAL PHARMA HEALTHCARE PVT LTD · 2 shipments · $2K | |||||||||||
| 40 | Nov 2025 | UNLISTED BUYER | Mozambique | Capsule | 800 | NOS | $1.11 | $886.48 | KATTUPALLI PORT SEA | Maputo | SEA |
| 41 | Nov 2025 | UNLISTED BUYER | Mozambique | Capsule | 700 | NOS | $1.87 | $1K | KATTUPALLI PORT SEA | Maputo | SEA |
| SUPPLIER #17 — LAVITA PHARMA PVT LTD · 2 shipments · $2K | |||||||||||
| 42 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 2.9K | NOS | $0.718 | $2K | AHMEDABAD ICD | DOUALA | ICD |
| 43 | Dec 2025 | UNLISTED BUYER | Cameroon | Tablet | 120 | NOS | $0.0001 | $0.014 | AHMEDABAD ICD | DOUALA | ICD |
| SUPPLIER #18 — GIANT INTERNATIONAL PVT LTD · 2 shipments · $2K | |||||||||||
| 44 | Oct 2025 | T.CHOITHRAM & SONS ( LIB.) INC | Liberia | Tablet | 1.8K | NOS | $1.01 | $2K | MUNDRA SEA | MONROVIA | SEA |
| 45 | Oct 2025 | T.CHOITHRAM & SONS ( LIB.) INC | Liberia | Tablet | 110 | NOS | $1.01 | $110.99 | MUNDRA SEA | MONROVIA | SEA |
| SUPPLIER #19 — JYOTI IMPEX · 2 shipments · $579.06 | |||||||||||
| 46 | Nov 2025 | GOOD HEALTH (PTY) LTD | Seychelles | 100 | NOS | $3.69 | $369.10 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR | |
| 47 | Nov 2025 | GOOD HEALTH (PTY) LTD | Seychelles | 100 | NOS | $2.10 | $209.96 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR | |
| SUPPLIER #20 — CAPSTONE EXPORT & IMPORT · 1 shipments · $404.52 | |||||||||||
| 48 | Oct 2025 | UNLISTED BUYER | Seychelles | Tablet | 2.0K | NOS | $0.202 | $404.52 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #21 — TRIDENT IMPEX · 1 shipments · $389.88 | |||||||||||
| 49 | Nov 2025 | ALLIANCE PHARMA SARL | Guinea-Bissau | Tablet | 200 | NOS | $1.95 | $389.88 | NHAVA SHEVA SEA (JNPT) | Dakar | SEA |
| SUPPLIER #22 — AKASH PHARMA EXPORTS · 1 shipments · $282.58 | |||||||||||
| 50 | Oct 2025 | AMDJERAS FIELD HOSPITAL | Chad | Tablet | 2.0K | NOS | $0.141 | $282.58 | COCHIN SEA | N'DJAMENA | AIR |
| SUPPLIER #23 — MEDICOS LIFESCIENCES · 1 shipments · $23.75 | |||||||||||
| 51 | Nov 2025 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | Tablet | 100 | NOS | $0.237 | $23.75 | AHMEDABAD AIR | LUSAKA | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
5 countries · 10 shipments · $31K · 5 Indian suppliers · 5 buyers
SHIPMENTS
10
USD
$31K
COUNTRIES
5
SUPPLIERS
5
BUYERS
5
HHI
5,035
concentrated
Top 5 destination countries in Asia
1
Nepal (58.4%)
$18K
2
Sri Lanka (40.3%)
$12K
3
Singapore (0.6%)
$197.40
4
Japan (0.4%)
$121.37
5
Malaysia (0.3%)
$85.82
Top 5 Indian suppliers into Asia
1
SANOFI INDIA LTD
$18K
2
TORRENT PHARMACEUTICALS LTD
$12K
3
SANITAS MEDTECH INSTITUTE PVT LTD
$197.40
4
KAIRALI AYURVEDIC PRODUCTS PVT LTD
$121.37
5
BABA AGENCIES
$85.82
Top 5 Asia importers
1
YETI PHARMACHEM DIST PVT LTD · Nepal
$18K
2
HATTON NATIONAL BANK PLC · Sri Lanka
$12K
3
SUCCESS INTER LINK PTE LTD · Singapore
$197.40
4
WAKABA NISHIDA · Japan
$121.37
5
VITAL RANK SDN BHD · Malaysia
$85.82
Top 2 dosage forms
1
Tablet
$31K
2
Capsule
$121.37
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 6 | $18K | $3K |
| Nov | 2 | $12K | $6K |
| Dec | 2 | $318.77 | $159.39 |
Shipment register · 10 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — SANOFI INDIA LTD · 6 shipments · $18K | |||||||||||
| 1 | Oct 2025 | YETI PHARMACHEM DIST PVT LTD | Nepal | Tablet | 3.0K | NOS | $0.739 | $2K | RAXAUL | KATHMANDU | ROAD |
| 2 | Oct 2025 | YETI PHARMACHEM DIST PVT LTD | Nepal | Tablet | 1.0K | NOS | $3.12 | $3K | RAXAUL | KATHMANDU | ROAD |
| 3 | Oct 2025 | YETI PHARMACHEM DIST PVT LTD | Nepal | Tablet | 5.0K | NOS | $0.562 | $3K | RAXAUL | KATHMANDU | ROAD |
| 4 | Oct 2025 | YETI PHARMACHEM DIST PVT LTD | Nepal | Tablet | 6.0K | NOS | $0.882 | $5K | RAXAUL | KATHMANDU | ROAD |
| 5 | Oct 2025 | YETI PHARMACHEM DIST PVT LTD | Nepal | Tablet | 1.0K | NOS | $1.51 | $2K | RAXAUL | KATHMANDU | ROAD |
| 6 | Oct 2025 | YETI PHARMACHEM DIST PVT LTD | Nepal | Tablet | 1.0K | NOS | $3.04 | $3K | RAXAUL | KATHMANDU | ROAD |
| SUPPLIER #2 — TORRENT PHARMACEUTICALS LTD · 1 shipments · $12K | |||||||||||
| 7 | Nov 2025 | HATTON NATIONAL BANK PLC | Sri Lanka | Tablet | 1.4M | NOS | $0.0086 | $12K | DELHI AIR | COLOMBO | AIR |
| SUPPLIER #3 — SANITAS MEDTECH INSTITUTE PVT LTD · 1 shipments · $197.40 | |||||||||||
| 8 | Dec 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 6 | NOS | $32.90 | $197.40 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #4 — KAIRALI AYURVEDIC PRODUCTS PVT LTD · 1 shipments · $121.37 | |||||||||||
| 9 | Dec 2025 | WAKABA NISHIDA | Japan | Capsule | 50 | NOS | $2.43 | $121.37 | BANGALORE AIR | TOKYO | AIR |
| SUPPLIER #5 — BABA AGENCIES · 1 shipments · $85.82 | |||||||||||
| 10 | Nov 2025 | VITAL RANK SDN BHD | Malaysia | Tablet | 300 | NOS | $0.286 | $85.82 | CHENNAI AIR | KUALA LUMPUR - INT'L | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
4 countries · 6 shipments · $192K · 4 Indian suppliers · 4 buyers
SHIPMENTS
6
USD
$192K
COUNTRIES
4
SUPPLIERS
4
BUYERS
4
HHI
3,315
concentrated
Top 4 destination countries in Europe
1
United Kingdom (39.3%)
$75K
2
Romania (35.8%)
$69K
3
Belgium (21.9%)
$42K
4
Netherlands (3.0%)
$6K
Top 4 Indian suppliers into Europe
1
GENO PHARMACEUTICALS PVT LTD
$75K
2
ZENTIVA PVT LTD
$69K
3
GRACURE PHARMACEUTICALS LTD
$42K
4
MICRO LABS LTD
$6K
Top 3 Europe importers
1
CRESCENT PHARMA LTD · United Kingdom
$75K
2
ZENTIVA S.A · Romania
$69K
3
IMRES B.V · Netherlands
$6K
Top 2 dosage forms
1
Tablet
$116K
2
Capsule
$75K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $186K | $37K |
| Nov | 0 | $0.0000 | — |
| Dec | 1 | $6K | $6K |
Shipment register · 6 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — GENO PHARMACEUTICALS PVT LTD · 1 shipments · $75K | |||||||||||
| 1 | Oct 2025 | CRESCENT PHARMA LTD | United Kingdom | Capsule | 187.2K | PCS | $0.402 | $75K | NHAVA SHEVA SEA (JNPT) | Felixstowe | SEA |
| SUPPLIER #2 — ZENTIVA PVT LTD · 1 shipments · $69K | |||||||||||
| 2 | Oct 2025 | ZENTIVA S.A | Romania | Tablet | 150.6K | PCS | $0.456 | $69K | NHAVA SHEVA SEA (JNPT) | Constanta | SEA |
| SUPPLIER #3 — GRACURE PHARMACEUTICALS LTD · 3 shipments · $42K | |||||||||||
| 3 | Oct 2025 | UNLISTED BUYER | Belgium | Tablet | 1.1M | NOS | $0.028 | $31K | PATLI ICD | ANTWERP CHURCHILL TE | ICD |
| 4 | Oct 2025 | UNLISTED BUYER | Belgium | Tablet | 387.0K | NOS | $0.028 | $11K | PATLI ICD | ANTWERP CHURCHILL TE | ICD |
| 5 | Oct 2025 | UNLISTED BUYER | Belgium | Tablet | 8 | NOS | $0.847 | $6.78 | PATLI ICD | ANTWERP CHURCHILL TE | ICD |
| SUPPLIER #4 — MICRO LABS LTD · 1 shipments · $6K | |||||||||||
| 6 | Dec 2025 | IMRES B.V | Netherlands | Tablet | 966 | NOS | $5.98 | $6K | HOSUR ICD | ROTTERDAM | ICD |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
6 countries · 19 shipments · $76K · 9 Indian suppliers · 8 buyers
SHIPMENTS
19
USD
$76K
COUNTRIES
6
SUPPLIERS
9
BUYERS
8
HHI
2,042
moderate
Top 6 destination countries in Americas
1
Dominican Republic (66.9%)
$51K
2
United States (19.0%)
$14K
3
Suriname (13.9%)
$11K
4
Venezuela (0.2%)
$155.25
5
Cayman Islands (0.0%)
$0.261
6
Panama (0.0%)
$0.031
Top 9 Indian suppliers into Americas
1
AMICO FORMULATIONS LLP
$24K
2
AJANTA PHARMA LTD
$14K
3
BALAXI PHARMACEUTICALS LTD
$14K
4
MEDOPHARM PVT LTD
$11K
5
ANH PHARMACEUTICALS PVT LTD
$8K
6
CUMED LIFESCIENCES
$5K
7
CURIANCE BIOTECH
$155.25
8
ZYPHARS PHARMACEUTICS PVT LTD
$0.261
9
TULSI MEDICAL & GENERAL STORES
$0.031
Top 6 Americas importers
1
MCKESSON THIRD PARTY LOGISTICS · United States
$14K
2
BALAXI HEALTHCARE DOMINICANA SRL · Dominican Republic
$14K
3
KERSTEN DISTRIBUTION N.V · Suriname
$11K
4
TO THE ODRER OF AARNEXT DOMINICANA · Dominican Republic
$8K
5
BERYL PHARMA SRL · Dominican Republic
$5K
6
XIOMARA BRITO · Venezuela
$155.25
Top 2 dosage forms
1
Tablet
$76K
2
Capsule
$155.29
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $17K | $6K |
| Nov | 8 | $10K | $1K |
| Dec | 8 | $49K | $6K |
Shipment register · 19 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — AMICO FORMULATIONS LLP · 1 shipments · $24K | |||||||||||
| 1 | Dec 2025 | UNLISTED BUYER | Dominican Republic | Tablet | 1.8K | THD | $13.67 | $24K | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| SUPPLIER #2 — AJANTA PHARMA LTD · 6 shipments · $14K | |||||||||||
| 2 | Oct 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Tablet | 56.4K | NOS | $0.014 | $785.52 | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 3 | Nov 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Tablet | 721.2K | NOS | $0.0067 | $5K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 4 | Nov 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Tablet | 28.8K | NOS | $0.0041 | $119.08 | MUMBAI AIR (SAHAR) | WASHINGTON | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 28.8K | NOS | $0.0041 | $119.08 | MUMBAI AIR (SAHAR) | WASHINGTON | AIR |
| 6 | Dec 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Tablet | 562.8K | NOS | $0.0076 | $4K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| 7 | Dec 2025 | MCKESSON THIRD PARTY LOGISTICS | United States | Tablet | 562.8K | NOS | $0.0076 | $4K | NHAVA SHEVA SEA (JNPT) | Norfolk | SEA |
| SUPPLIER #3 — BALAXI PHARMACEUTICALS LTD · 4 shipments · $14K | |||||||||||
| 8 | Oct 2025 | BALAXI HEALTHCARE DOMINICANA SRL | Dominican Republic | Tablet | 8.3K | TBS | $0.636 | $5K | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| 9 | Nov 2025 | BALAXI HEALTHCARE DOMINICANA SRL | Dominican Republic | Tablet | 600 | TBS | $0.638 | $382.75 | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| 10 | Dec 2025 | BALAXI HEALTHCARE DOMINICANA SRL | Dominican Republic | Tablet | 10.2K | TBS | $0.634 | $6K | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| 11 | Dec 2025 | BALAXI HEALTHCARE DOMINICANA SRL | Dominican Republic | Tablet | 3.0K | TBS | $0.642 | $2K | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| SUPPLIER #4 — MEDOPHARM PVT LTD · 1 shipments · $11K | |||||||||||
| 12 | Oct 2025 | KERSTEN DISTRIBUTION N.V | Suriname | Tablet | 10.0K | NOS | $1.05 | $11K | ENNORE SEA | Paramaribo | SEA |
| SUPPLIER #5 — ANH PHARMACEUTICALS PVT LTD · 1 shipments · $8K | |||||||||||
| 13 | Dec 2025 | TO THE ODRER OF AARNEXT DOMINICANA | Dominican Republic | Tablet | 1.6K | THD | $5.03 | $8K | NHAVA SHEVA SEA (JNPT) | CAUCEDO DOMINIC REP. | SEA |
| SUPPLIER #6 — CUMED LIFESCIENCES · 2 shipments · $5K | |||||||||||
| 14 | Nov 2025 | BERYL PHARMA SRL | Dominican Republic | Tablet | 3.0K | NOS | $0.639 | $2K | NHAVA SHEVA SEA (JNPT) | Rio Haina | SEA |
| 15 | Nov 2025 | BERYL PHARMA SRL | Dominican Republic | Tablet | 3.0K | NOS | $0.905 | $3K | NHAVA SHEVA SEA (JNPT) | Rio Haina | SEA |
| SUPPLIER #7 — CURIANCE BIOTECH · 2 shipments · $155.25 | |||||||||||
| 16 | Nov 2025 | XIOMARA BRITO | Venezuela | Capsule | 1 | NOS | $7.76 | $7.76 | MUMBAI AIR (SAHAR) | CARACAS | AIR |
| 17 | Nov 2025 | XIOMARA BRITO | Venezuela | Capsule | 19 | NOS | $7.76 | $147.49 | MUMBAI AIR (SAHAR) | CARACAS | AIR |
| SUPPLIER #8 — ZYPHARS PHARMACEUTICS PVT LTD · 1 shipments · $0.261 | |||||||||||
| 18 | Dec 2025 | UNKNOWN BUYER | Cayman Islands | Tablet | 10 | NOS | $0.026 | $0.261 | MUMBAI AIR (SAHAR) | GRAND CAYMAN | AIR |
| SUPPLIER #9 — TULSI MEDICAL & GENERAL STORES · 1 shipments · $0.031 | |||||||||||
| 19 | Dec 2025 | UNLISTED BUYER | Panama | Capsule | 9 | NOS | $0.0034 | $0.031 | MUMBAI AIR (SAHAR) | PANAMA CITY - | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 1 shipments · $210.38 · 1 Indian suppliers · 1 buyers
SHIPMENTS
1
USD
$210.38
COUNTRIES
1
SUPPLIERS
1
BUYERS
1
HHI
10,000
concentrated
Top 1 destination countries in Oceania
1
Papua New Guinea (100.0%)
$210.38
Top 1 Indian suppliers into Oceania
1
CHOUDHARI IMPEX
$210.38
Top 0 Oceania importers
Top 1 dosage forms
1
Capsule
$210.38
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 1 | $210.38 | $210.38 |
| Dec | 0 | $0.0000 | — |
Shipment register · 1 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CHOUDHARI IMPEX · 1 shipments · $210.38 | |||||||||||
| 1 | Nov 2025 | UNLISTED BUYER | Papua New Guinea | Capsule | 3.6K | NOS | $0.058 | $210.38 | CHENNAI SEA | Port Moresby | SEA |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 41 Indian captopril exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped captopril in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | AGOG PHARMA LTD | VASAI EAST | 2 | $102K | Tablet | Africa |
| 2 | GENO PHARMACEUTICALS PVT LTD | MAPUCA | 1 | $75K | Capsule | Europe |
| 3 | ZENTIVA PVT LTD | MUMBAI | 1 | $69K | Tablet | Europe |
| 4 | MIHIKA PHARMACEUTICALS | MUMBAI | 2 | $60K | Capsule | Africa |
| 5 | TORRENT PHARMACEUTICALS LTD | AHMEDABAD. GUJARAT | 7 | $45K | Tablet | Africa, Asia |
| 6 | GRACURE PHARMACEUTICALS LTD | BHIWADI | 3 | $42K | Tablet | Europe |
| 7 | MEDISKY PHARMACEUTICALS PVT LTD | AHMEDABAD | 5 | $38K | Tablet | Africa |
| 8 | AMICO FORMULATIONS LLP | COLABA | 1 | $24K | Tablet | Americas |
| 9 | SANOFI INDIA LTD | VADAPE | 6 | $18K | Tablet | Asia |
| 10 | J B CHEMICALS AND PHARMACEUTICALS LTD | MUMBAI | 5 | $15K | Tablet | Africa |
| 11 | AJANTA PHARMA LTD | MUMBAI. | 6 | $14K | Tablet | Americas |
| 12 | BALAXI PHARMACEUTICALS LTD | JUBILEE HILLS HYDERABAD | 4 | $14K | Tablet | Americas |
| 13 | UMAVIDA PHARMA PVT LTD | MEHSANA | 2 | $13K | Tablet | Africa |
| 14 | REGAL LABORATORIES | TARN TARAN | 5 | $11K | Tablet | Africa |
| 15 | MEDOPHARM PVT LTD | CHENNAI TAMILNADU | 1 | $11K | Tablet | Americas |
| 16 | ANGEL BIOGENICS PVT LTD | RAJKOT | 1 | $8K | Tablet | Africa |
| 17 | ANH PHARMACEUTICALS PVT LTD | VADODARA | 1 | $8K | Tablet | Americas |
| 18 | MICRO LABS LTD | HOSUR | 1 | $6K | Tablet | Europe |
| 19 | ANETA PHARMACEUTICALS PVT LTD | AHMEDABAD | 2 | $5K | Tablet | Africa |
| 20 | SARTHI PHARMA | RAJKOT | 2 | $5K | Tablet | Africa |
| 21 | CUMED LIFESCIENCES | DELHI | 2 | $5K | Tablet | Americas |
| 22 | AURA LIFECARE PVT LTD | KARACHIYA TAL SAVLI | 1 | $5K | Tablet | Africa |
| 23 | BIOMATRIX HEALTHCARE PVT LTD | AHMADABAD | 1 | $4K | Tablet | Africa |
| 24 | VIAN INTERNATIONAL | SIDHPUR | 2 | $4K | Tablet | Africa |
| 25 | BENLEX TRADING PVT LTD | BHAYANDER | 2 | $4K | Tablet | Africa |
| 26 | SHALINA LABORATORIES PVT LTD | MUMBAI | 1 | $3K | Tablet | Africa |
| 27 | GLOBAL PHARMA HEALTHCARE PVT LTD | KANCHIPURAM THIRUPORUR | 2 | $2K | Capsule | Africa |
| 28 | LAVITA PHARMA PVT LTD | AHMEDABAD | 2 | $2K | Tablet | Africa |
| 29 | GIANT INTERNATIONAL PVT LTD | JAIPUR | 2 | $2K | Tablet | Africa |
| 30 | JYOTI IMPEX | MUMBAI | 2 | $579.06 | Africa | |
| 31 | CAPSTONE EXPORT & IMPORT | CHENNAI | 1 | $404.52 | Tablet | Africa |
| 32 | TRIDENT IMPEX | MUMBAI | 1 | $389.88 | Tablet | Africa |
| 33 | AKASH PHARMA EXPORTS | PALAKKAD | 1 | $282.58 | Tablet | Africa |
| 34 | CHOUDHARI IMPEX | CHENNAI | 1 | $210.38 | Capsule | Oceania |
| 35 | SANITAS MEDTECH INSTITUTE PVT LTD | Narhen | 1 | $197.40 | Tablet | Asia |
| 36 | CURIANCE BIOTECH | Raipur | 2 | $155.25 | Capsule | Americas |
| 37 | KAIRALI AYURVEDIC PRODUCTS PVT LTD | NEW DELHI | 1 | $121.37 | Capsule | Asia |
| 38 | BABA AGENCIES | Chennai | 1 | $85.82 | Tablet | Asia |
| 39 | MEDICOS LIFESCIENCES | AHMEDABAD | 1 | $23.75 | Tablet | Africa |
| 40 | ZYPHARS PHARMACEUTICS PVT LTD | PUNE | 1 | $0.261 | Tablet | Americas |
| 41 | TULSI MEDICAL & GENERAL STORES | MUMBAI | 1 | $0.031 | Capsule | Americas |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 31 global captopril importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian captopril in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | RWANDA MEDICAL SUPPLY LTD | Kenya | 1 | $101K | AGOG PHARMA LTD | Tablet |
| 2 | CRESCENT PHARMA LTD | United Kingdom | 1 | $75K | GENO PHARMACEUTICALS… | Capsule |
| 3 | ZENTIVA S.A | Romania | 1 | $69K | ZENTIVA PVT LTD | Tablet |
| 4 | KARURI PHARMACEUTICALS LTD | Uganda | 3 | $26K | TORRENT PHARMACEUTIC… | Tablet |
| 5 | YETI PHARMACHEM DIST PVT LTD | Nepal | 6 | $18K | SANOFI INDIA LTD | Tablet |
| 6 | BIOTECH LABORATORIES (PTY) LTDDELIV | South Africa | 5 | $15K | J B CHEMICALS AND PH… | Tablet |
| 7 | MCKESSON THIRD PARTY LOGISTICS | United States | 5 | $14K | AJANTA PHARMA LTD | Tablet |
| 8 | BALAXI HEALTHCARE DOMINICANA SRL | Dominican Republic | 4 | $14K | BALAXI PHARMACEUTICA… | Tablet |
| 9 | HATTON NATIONAL BANK PLC | Sri Lanka | 1 | $12K | TORRENT PHARMACEUTIC… | Tablet |
| 10 | KERSTEN DISTRIBUTION N.V | Suriname | 1 | $11K | MEDOPHARM PVT LTD | Tablet |
| 11 | TO THE ODRER OF AARNEXT DOMINICANA | Dominican Republic | 1 | $8K | ANH PHARMACEUTICALS … | Tablet |
| 12 | SONIA PHARMACIA | Equatorial Guinea | 2 | $8K | REGAL LABORATORIES | Tablet |
| 13 | PHARMACEUTICAL AND CHEMICAL DISTRIB | Zimbabwe | 3 | $7K | TORRENT PHARMACEUTIC… | Tablet |
| 14 | IMRES B.V | Netherlands | 1 | $6K | MICRO LABS LTD | Tablet |
| 15 | UNIPLUS FARMA,LDA | Angola | 2 | $5K | ANETA PHARMACEUTICAL… | Tablet |
| 16 | BERYL PHARMA SRL | Dominican Republic | 2 | $5K | CUMED LIFESCIENCES | Tablet |
| 17 | ARAUPHAR S.A | Tanzania | 1 | $5K | AURA LIFECARE PVT LTD | Tablet |
| 18 | UNIQUE PHARMA | DR Congo | 1 | $4K | BIOMATRIX HEALTHCARE… | Tablet |
| 19 | PHARMA ESPOIR SARL | Cote d'Ivoire | 2 | $4K | BENLEX TRADING PVT LTD | Tablet |
| 20 | SHALINA HEALTHCARE SARL | Tanzania | 1 | $3K | SHALINA LABORATORIES… | Tablet |
| 21 | SONIA PHARMACY | Equatorial Guinea | 3 | $3K | REGAL LABORATORIES | Tablet |
| 22 | T.CHOITHRAM & SONS ( LIB.) INC | Liberia | 2 | $2K | GIANT INTERNATIONAL … | Tablet |
| 23 | SUN ENTERPRISES LTD | Tanzania | 1 | $1K | AGOG PHARMA LTD | Tablet |
| 24 | GOOD HEALTH (PTY) LTD | Seychelles | 2 | $579.06 | JYOTI IMPEX | |
| 25 | ALLIANCE PHARMA SARL | Guinea-Bissau | 1 | $389.88 | TRIDENT IMPEX | Tablet |
| 26 | AMDJERAS FIELD HOSPITAL | Chad | 1 | $282.58 | AKASH PHARMA EXPORTS | Tablet |
| 27 | SUCCESS INTER LINK PTE LTD | Singapore | 1 | $197.40 | SANITAS MEDTECH INST… | Tablet |
| 28 | XIOMARA BRITO | Venezuela | 2 | $155.25 | CURIANCE BIOTECH | Capsule |
| 29 | WAKABA NISHIDA | Japan | 1 | $121.37 | KAIRALI AYURVEDIC PR… | Capsule |
| 30 | VITAL RANK SDN BHD | Malaysia | 1 | $85.82 | BABA AGENCIES | Tablet |
| 31 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | 1 | $23.75 | MEDICOS LIFESCIENCES | Tablet |
This report covers 87 2025-Q4 Captopril shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/captopril
Talk to our trade analyst
Need a custom captopril report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/captopril
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Captopril product page
Live data, supplier directory, price trends, and trade route analysis